Printer Friendly

GAMMA BIOLOGICALS SELLS PLASTICS MANUFACTURING OPERATION

 GAMMA BIOLOGICALS SELLS PLASTICS MANUFACTURING OPERATION
 HOUSTON, May 11 /PRNewswire/ -- In keeping with management's plan to


concentrate on its core business, Gamma Biologicals, Inc. (AMEX: GBL), today announced the sale of its plastics manufacturing operation to J B Plastics, Inc., a Texas corporation. The sale, effective April 1, 1992, calls for payment of an amount equal to book value (approximately $220,000 of inventory and equipment), due in monthly installments over three years.
 Terms of the sales agreement are designed to assure Gamma continuing supplies of plastic specialty items essential to its ongoing business.
 "By reducing overhead expenses, we expect the sale to have a positive effect on operating income of approximately $100,000 per year," stated Chairman David E. Hatcher.
 Gamma Biologicals manufactures and markets a wide range of highly refined and specialized testing products, known as diagnostic reagents, as well as sophisticated instrument systems. The company markets to hospitals, blood banks, medical laboratories, physicians' offices and research institutions.
 -0- 5/11/92
 /CONTACT: David E. Hatcher, chairman and president, or John J. Moulds, executive vice president of Gamma Biologicals, 713-660-7990/
 (GBL) CO: Gamma Biologicals, Inc. ST: Texas IN: SU: TNM


GK -- NY063 -- 8619 05/11/92 12:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1992
Words:201
Previous Article:BASSIST FRANCIS BUCHHOLZ LEAVES THE SCORPIONS
Next Article:SECRETARY CARD LAUNCHES TRANSPORTATION WEEK, DOT ANNIVERSARY CELEBRATION
Topics:


Related Articles
News in medical-grade plastics.
FINAL CASH SETTLEMENT ON ITALIAN SALE TO FUND BIOELECTRICAL SENSOR TECHNOLOGY DEVELOPMENT FOR GAMMA BIOLOGICALS
ANOTHER FIRST FOR GAMMA BIOLOGICALS; COMPANY RECEIVES FIRST EVER LICENSE FOR MONOCLONAL COOMBS REAGENTS
GAMMA BIOLOGICALS REPORTS FIRST QUARTER EARNINGS
GAMMA BIOLOGICALS REPORTS STRONG EARNINGS FOR QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 1993
GAMMA BIOLOGICALS' BOARD OF DIRECTORS DECLARES DIVIDEND AND AUTHORIZES SHARE REPURCHASE
GAMMA BIOLOGICALS REPORTS EARNINGS FOR FISCAL YEAR ENDED MARCH 31, 1994
GAMMA ORDERS FIELD TEST CENTRIFUGES FOR REACT(TM) TEST SYSTEM
Gamma Biologicals Expands Product Line through Distribution Agreement with GTI
Allibert group goes Stateside.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters